{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:56:35Z","timestamp":1790200595120,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:p>\n                    Complex microbial ecosystems in both gastrointestinal and respiratory systems have been found to have a significant impact on human health. Growing evidence has demonstrated that intestinal dysbiosis can increase vulnerability to pulmonary infections. However, changes in the composition and activity of the intestinal flora after probiotic supplementation may alter the disease state of the host. The effects of probiotics on the improvement of diseases, such as severe pneumonia (SP), in intensive care units (ICUs) remain controversial. We retrospectively included 88 patients diagnosed with severe pneumonia between April 2021 and June 2022. The patients were divided into 2 groups: a probiotic group (n\u2005=\u200540) and a control group (n\u2005=\u200548). In addition, changes in CRP, PCT, WBC, IL-6, Clostridium difficile toxin, and PSI pneumonia scores were assessed. Changes in the gut microbiome of the patients were assessed using amplicon sequencing. Compared to the control group, a significant reduction in the incidence of length of hospital stay was observed in the probiotic group, but there were no significant differences in the mortality rate, duration of fever, diarrhea, and constipation. After probiotic treatment, CRP, PCT, WBC, and PSI score were significantly lower than before, and better clinical efficacy was achieved in the probiotic group for the duration of antibiotic therapy. Gut microbiota analysis revealed that the abundance of opportunistic pathogens (e.g.,\n                    <jats:italic toggle=\"yes\">Massilia<\/jats:italic>\n                    ) increased remarkably at the genus level in the control group, and a significant increase in\n                    <jats:italic toggle=\"yes\">Erysipelotrichaceae_ge<\/jats:italic>\n                    was observed after probiotic intervention. The control group showed an increase in opportunistic pathogens (\n                    <jats:italic toggle=\"yes\">Citrobacter, Massilia<\/jats:italic>\n                    ) during the antibiotic treatment. Probiotics interventions inhibit the growth of opportunistic pathogens. In addition, we found that the population of butyrate-producing bacteria (e.g.,\n                    <jats:italic toggle=\"yes\">Ruminococcaceae UCG-005<\/jats:italic>\n                    ) increased following probiotic treatment.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000036320","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T22:00:05Z","timestamp":1701468005000},"page":"e36320","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3976-5417","authenticated-orcid":false,"given":"Yonglin","family":"Zhu","sequence":"first","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Ma","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China"},{"name":"Beijing D.A. Medical Laboratory, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingding","family":"Zhang","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China"},{"name":"Beijing D.A. Medical Laboratory, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetong","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China"},{"name":"Beijing D.A. Medical Laboratory, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Chen","sequence":"additional","affiliation":[{"name":"Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among US Adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"2019 Cancer Risk Factors Collaborators The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thoraxjnl-2015-207688","article-title":"Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014.","volume":"71","author":"Quan","year":"2016","journal-title":"Thorax"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13613-018-0430-6","article-title":"Ten-year trends in intensive care admissions for respiratory infections in the elderly.","volume":"8","author":"Laporte","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R5-20260811","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","article-title":"The burden of community-acquired pneumonia requiring admission to ICU in the United States.","volume":"158","author":"Cavallazzi","year":"2020","journal-title":"Chest"},{"key":"R6-20260811","doi-asserted-by":"crossref","first-page":"e065871","DOI":"10.1136\/bmj-2021-065871","article-title":"Management of pneumonia in critically ill patients.","volume":"375","author":"Cill\u00f3niz","year":"2021","journal-title":"BMJ"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.chom.2011.10.001","article-title":"The Human Microbiome Project in 2011 and beyond.","volume":"10","author":"Proctor","year":"2011","journal-title":"Cell Host Microbe"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"e8578","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways.","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS One"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.11-0774","article-title":"Advancing respiratory research.","volume":"140","author":"Kiley","year":"2011","journal-title":"Chest"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"e16384","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the lung microbiome in the \u201chealthy\u201d smoker and in COPD.","volume":"6","author":"Erb-Downward","year":"2011","journal-title":"PLoS One"},{"key":"R11-20260811","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/embor.2012.32","article-title":"Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma.","volume":"13","author":"Russell","year":"2012","journal-title":"EMBO Rep"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2014.06.027","article-title":"Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases.","volume":"135","author":"Russell","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"10410","DOI":"10.1038\/ncomms10410","article-title":"Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children.","volume":"7","author":"Korpela","year":"2016","journal-title":"Nat Commun"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"eaba0501","DOI":"10.1126\/scitranslmed.aba0501","article-title":"The microbiota in pneumonia: From protection to predisposition.","volume":"13","author":"Thibeault","year":"2021","journal-title":"Sci Transl Med"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1073\/pnas.1019378108","article-title":"Microbiota regulates immune defense against respiratory tract influenza A virus infection.","volume":"108","author":"Ichinohe","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20260811","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/SHK.0b013e3182184ee7","article-title":"Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors.","volume":"36","author":"Chen","year":"2011","journal-title":"Shock"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/gutjnl-2015-309728","article-title":"The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.","volume":"65","author":"Schuijt","year":"2016","journal-title":"Gut"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.2021.21216","article-title":"Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients.","volume":"327","author":"Wang","year":"2022","journal-title":"JAMA"},{"key":"R19-20260811","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2021.13355","article-title":"Effect of probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.","volume":"326","author":"Johnstone","year":"2021","journal-title":"JAMA"},{"key":"R20-20260811","doi-asserted-by":"crossref","first-page":"635471","DOI":"10.3389\/fimmu.2021.635471","article-title":"Microbiota Modulation of the Gut-Lung Axis in COVID-19.","volume":"12","author":"de Oliveira","year":"2021","journal-title":"Front Immunol"},{"key":"R21-20260811","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3906\/biy-2005-102","article-title":"Gut-lung axis and dysbiosis in COVID-19.","volume":"44","author":"Aktas","year":"2020","journal-title":"Turk J Biol"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.","volume":"185","author":"Meyer","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20260811","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT).","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R24-20260811","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/0885066619826045","article-title":"Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia.","volume":"35","author":"Baek","year":"2020","journal-title":"J Intensive Care Med"},{"key":"R25-20260811","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcrc.2018.07.029","article-title":"Response to letter to the editor noninvasive and invasive ventilation in severe pneumonia: Insight for the noninvasive ventilator approach.","volume":"48","author":"Stefan","year":"2018","journal-title":"J Crit Care"},{"key":"R26-20260811","first-page":"566","article-title":"Pneumonia in the elderly--what makes the difference?","volume":"112","author":"Sch\u00e4fer","year":"2000","journal-title":"Wien Klin Wochenschr"},{"key":"R27-20260811","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12877-021-02267-x","article-title":"Clinical characteristics and factors related to antibiotic-associated diarrhea in elderly patients with pneumonia: a retrospective cohort study.","volume":"21","author":"Takedani","year":"2021","journal-title":"BMC Geriatr"},{"key":"R28-20260811","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2021.13355","article-title":"Effect of on incident ventilator-associated pneumonia in critically ill patients: a Randomized Clinical Trial.","volume":"326","author":"Johnstone","year":"2021","journal-title":"JAMA"},{"key":"R29-20260811","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/nu14081600","article-title":"Probiotics for the prevention of ventilator-associated pneumonia: an updated systematic review and meta-analysis of Randomised Controlled Trials.","volume":"14","author":"Cheema","year":"2022","journal-title":"Nutrients"},{"key":"R30-20260811","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-022-03337-3","article-title":"Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4\/NF-kB signaling pathway.","volume":"20","author":"Wu","year":"2022","journal-title":"J Transl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:01:40Z","timestamp":1786435300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":30,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036320","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}